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Abstract 
 
BMP-SIGNALING REGULATES A COMMON TRANSCRIPTIONAL PROGRAM 
TO CONTROL FACIAL FORM AND SKELETAL MORPHOGENESIS 
 
Publication No._______ 
Margarita Bonilla-Claudio, B.S. 
Supervisory Professor: James F. Martin, M.D., Ph.D. 
 
Much of the craniofacial skeleton, such as the skull vault, mandible and midface, 
develops through direct, intramembranous ossification of the cranial neural crest 
(CNC) derived progenitor cells.  Bmp-signaling plays critical roles in normal 
craniofacial development, and Bmp4 deficiency results in craniofacial abnormalities, 
such as cleft lip and palate.  We performed an in depth analysis of Bmp4, a critical 
regulator of development, disease, and evolution, in the CNC. Conditional Bmp4 
overexpression, using a tetracycline regulated Bmp4 gain of function allele, resulted 
in facial form changes that were most dramatic after an E10.5 Bmp4 induction. 
Expression profiling uncovered a signature of Bmp4 induced genes (BIG) 
composed predominantly of transcriptional regulators controlling self-renewal, 
osteoblast differentiation, and negative Bmp autoregulation.  The complimentary 
experiment, CNC inactivation of Bmp2, Bmp4, and Bmp7, resulted in complete or 
partial loss of multiple CNC derived skeletal elements revealing a critical 
requirement for Bmp-signaling in membranous bone and cartilage development. 
vi 
 
Importantly, the BIG signature was reduced in Bmp loss of function mutants 
indicating similar Bmp-regulated target genes underlying facial form modulation and 
normal skeletal morphogenesis. Chromatin immunoprecipitation (ChIP) revealed a 
subset of the BIG signature, including Satb2, Smad6, Hand1, Gadd45γ and Gata3 
that was bound by Smad1/5 in the developing mandible revealing direct, Smad-
mediated regulation. These data indicate that Bmp-signaling regulates craniofacial 
skeletal development and facial form by balancing self-renewal and differentiation 
pathways in CNC progenitors.  
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The cranial neural crest (CNC) cells are a migratory cell population that 
originates from the dorsal neural tube during neurulation (Fig. 1 A).  CNC diversifies 
into multiple cell types including cartilage, bone, smooth muscles, neurons, glia, and 
connective tissues of the blood vessels.  Migration of the CNC occurs in three 
recognized streams, trigeminal, hyoid, and post-octic (Fig. 1 B).  Each stream has 
been traced from their origin to their final fate.  CNC arising from rhombomers 1 and 
2, forms the trigeminal ganglion neurons and craniofacial components, including the 
mandible.  Meanwhile, CNC originating from rhombomere 4 give rise to neurons of 
the proximal facial ganglion and hyoid skeleton.  Lastly, CNC originating from 
rhombomere 6 and 7 forms neurons of the proximal jugular ganglia and pharyngeal 
arches skeletal components (Graham et al., 2004).   
 
Much of the craniofacial skeleton components, including the skull vault or 
calvarium, mandible, and midface develops through direct, intramembranous 
ossification of CNC-derived progenitor cells (Fig. 2) (Chai and Maxson, 2006). For 
example, in the skull, osteogenesis occurs at discrete areas within the cranial 
mesenchyme resulting in the flat bones of the skull forming between the central 
nervous system (CNS) and overlying ectoderm (Jiang et al., 2002).  The mandible 
and most midfacial bones develop by direct ossification of CNC-derived branchial 
arch mesenchyme (Nie et al., 2006). 
The complexity of neural crest cell formation involves a number of key 
signaling regulators, such as those mediated by the Wnt, Fibroblast growth factor  
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Figure 1.  Formation and migration of the CNC.  
(A)  CNC is induced at the neural plate border.  After neurulation, delamination of 
cells between the ectoderm and the dorsal neural tube give rise to CNC (Knecht 
and Bronner-Fraser, 2002).  (B)  Migration of the CNC occurs in three recognized 
streams, trigeminal (red), hyoid (green), and post-octic (purple) (Graham et al., 
2004).   
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Figure 2.  Origin of the skeletal elements of the skull.   
Adult mouse skull showing the CNC- and mesoderm- derived bones (Noden and 
Trainor, 2005). 
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 (Fgf) and Bone morphogenic protein (Bmp) pathways (Knecht and Bronner-Fraser, 
2002).  For example, studies have shown the importance of Bmp-signaling in the 
specification of the neural plate and neural crest cells (Tribulo et al., 2003).  
Furthermore, migration of the CNC cells to the facial primordia also involves the 
participation of Bmp-mediated signaling.  Inhibition of Bmp2 and Bmp4 in the CNC 
results in hypomorphic branchieal arches, while neural and skeletal derivates did 
not develop (Kanzler et al., 2000). 
Bmp-signaling plays a critical role in normal craniofacial development. 
Several studies have elegantly demonstrated that Bmp4 deficiency results in 
craniofacial anomalies, such as cleft lip and palate, in mouse and humans (Liu et 
al., 2005b; Suzuki et al., 2009). In the mandible, Bmp4 has been shown to regulate 
proximo-distal patterning and timing of bone differentiation in mandibular 
mesenchyme (Liu et al., 2005a; Merrill et al., 2008). There is strong evidence that 
Bmp-signaling regulates craniofacial morphologic change during evolution. Both 
gain of function studies and comparative expression data revealed Bmp4 to be a 
critical regulator of beak shape in Darwin’s finches, a classic model of evolutionary 
diversification (Abzhanov et al., 2004; Wu et al., 2004). Other experiments in Cichlid 
fish also support the notion that Bmp4 is a major regulator of craniofacial cartilage 
shape and morphologic adaptive radiation (Albertson et al., 2005). In summary, 
while the role of Bmp-signaling in craniofacial development has been well studied, 
the downstream genes regulated in response to Bmp-signaling remain poorly 
understood.   
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Recent molecular insights into Bmp-signaling indicate that the downstream 
effector mechanisms for Bmp-signaling are complex and require further study 
(Wang et al., 2011).  The canonical Bmp pathway involves nucleo-cytoplasmic 
shuttling of Smad effectors in response to Bmp-signaling.  Bmp, as members of the 
TGF family, are dimeric ligands that bind to a pair of membrane BMP receptor type I 
and type II (BMPRI and BMPRII).  These serine/threonine kinase receptors form a 
hetero-tetramer receptor complex, while type II receptors can phosphorylate type I 
receptors at the cytoplasmic region.  Upon phosphorylation, a docking site is 
created that enables receptor-regulated Smad proteins (Smad1, Smad5 and 
Smad8) binding and further activation (Massague et al., 2005).  Phosphorylated 
receptor-regulated Smad protein can then associate with Smad4 and form a 
heterodimer complex capable of regulating gene expression (Nohe et al., 2004). 
In addition, several studies have shown that Smad-independent mechanisms 
mediated through MAPK pathways, can play an important role in tooth development 
(Xu et al., 2008). More recent work, uncovered a third Bmp effector mechanism, 
revealing that Smad1/5 can directly bind to the Drosha complex to promote 
microRNA (miR) processing (Davis et al., 2008). Furthermore, our group has shown 
that Bmp-signaling can induce miR transcription through a canonical Smad 
regulated mechanism (Wang et al., 2010).   Despite the central importance of Bmp 
signaling for craniofacial development, congenital defects, and evolution, the 
mechanisms underlying Bmp action in CNC remains poorly understood.  
In this study, we investigated Bmp signaling in CNC development using both 
gain and loss of function approaches. Inactivation of Bmp2, Bmp4, and Bmp7 in 
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CNC indicate that Bmp2 and Bmp4 are the major Bmp ligands required for 
development of CNC-derived bone and cartilage. Moreover, gain of function studies 
indicate that elevated Bmp4 in CNC results in dramatic changes in facial shape. 
Expression profiling and quantitative RT-PCR (qRT-PCR) studies uncovered a 
common set of Bmp-regulated target genes in both gain and loss of function 
embryos. Subsets of Bmp-regulated targets were directly bound by Smad 1/5 
indicating direct regulation. Our data suggest a role for Bmp-regulated genes to 
modulate self-renewal, osteoblast differentiation, and negative feedback regulation. 
Moreover, we suggest that Bmp signaling is a key player in skeletal morphogenesis 
and facial shape by controlling the balance between self-renewing progenitors and 
differentiating lineage restricted cells. Negative feedback regulation, a mechanism 
used to finely modulate Bmp-signaling levels, is likely a general output of Bmp-
signaling in multiple contexts.  
8 
 
 
 
 
 
 
 
 
Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
9 
 
Mouse alleles and transgenic lines.   
The generation and characterization of Bmp2 and Bmp4 conditional null mice 
and Wnt1Cre transgene mice have been previously described (Liu et al., 2004; Ma 
and Martin, 2005 and Chai, 2000). The conditional Bmp7 null allele will be 
described elsewhere (Bai Y and Martin JF, unpublished) (Appendix 1).   
To generate the Bmp4TetO allele we constructed a targeting vector that 
resulted in a 665 bp deletion upstream of and including the Bmp4 basal promoter 
and Bmp4 exon 1.  We modified the TetO plasmid that was a kind gift from 
Raymond MacDonald laboratory at The University of Texas Southwestern Medical 
Center.  The plasmid contains the tetracycline operator (TetO7), CMV promoter, 
IRES-lacZ and a poly-adenylation sequence.  Bmp4 genomic DNA was isolated 
from the 129/S BAC library.  A 9-kb EcoRI fragment of Bmp4 genomic DNA was 
subcloned into pBluescript (Stratagene).  We inserted Bmp4 cDNA into NotI and 
KasI sites downstream of the TetO7 and CMV promoter.  The phosphoglycerol 
kinase neomycin-resistance cassette (pgk-neo) with two flanking Frt sites was blunt 
cloned into the AscI site downstream of the IRES-LacZ.  The 3 kb 3’ homology arm 
was amplified by PCR using the primers (5’-3’) tgagcagggcaacctggagaggg and 
tccgaatggcactacggaatggct and blunt end ligated into SwaI site downstream of pgk-
neo.  The Bmp4TetO 5’ arm, 1.7 kb EcoRI-ApaLI fragment, was cut from Bmp4 
genomic DNA and blunt end cloned into XhoI site upstream of the tetO7.  The 
targeting construct was linearized with PmeI and electroporated into AK7 embryonic 
stem cells, selected in G418, and screened by Southern blot.  The cells were 
10 
 
digested with EcoRV and Bmp4 Exon 4 was used as the 3’ flanking probe.  Wild 
type allele gives a 22 kb EcoRV fragment and the targeted allele give a 16kb 
EcoRV fragment.  The targeting frequency for the TetO allele is 4.2% (7/167).  We 
also used a Spe1 digest to confirm correct targeting: the wild type band was 6.4 kb, 
the cDNA band was 11.7 kb, and the mutant allele was 8.0 kb.  We used the Rosa 
26 rtTA allele (Belteki et al., 2005) to express the reverse tetracycline activator (Tet-
on) under the control of the Wnt1cre allele.  This will drive Bmp4TetO allele expression 
on the neural crest cells in the presence of doxycycline. 
 
Doxycycline administration in mice.  
Pregnant females were given doxycycline (Sigma) in the drinking water 
(2mg/ml) and in the food (Bio-Serv; 200mg/kg), for a 24 hour period unless 
otherwise specified.   
 
Skeletal analysis.   
Dissected embryos were placed overnight in water and scalded in hot water 
for 30 seconds.  The skin and internal organs were removed and the samples were 
fixed overnight in 95% ethanol.  The cartilage was stained with 0.15mg/ml Alcian 
Blue (Sigma) in a 1:4 mixture of glacial acetic acid and 95% ethanol.  After staining 
overnight, the samples were rinsed twice in 95% ethanol and incubated for 24 hrs in 
95% ethanol. In preparation for bone staining, samples were placed in 2% KOH for 
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1 hr. Bones were stained using 0.05mg/ml of Alizarin red (Sigma) diluted in 2% 
KOH for 2-4 hrs and then cleared with glycerol. 
 
Alkaline Phosphatase staining. 
E14.5 embryos were dissected, decapitated and fixed in 4% 
paraformaldehyde for 1 hour. Heads were bisected mid-sagittally and the brain and 
dura mater removed, washed three times in phosphate buffered saline  
(PBS) and Alkaline phosphatase buffer (100mM NaCl; 100mM TrisHCl pH 9.5; 
50mM MgCl2; 0.1% Tween-20; 2mM Levimasole). A combination of nitro-blue 
tetrazolium chloride and 5-bromo-4-chloro-3’-indolyphosphate p-toluidine salt 
(NBT/BCIP) (Roche) substrate in Alkaline phosphatase buffer was added until bone 
staining was observed. Samples were then washed in PBS, and post-fixed in 4% 
paraformaldehyde.  
 
Western Blot 
Cell lysates were prepared by dissecting E11.5 mandibles in PBS. Tissue 
was then homogenized in lysis buffer (50 mmol/L Tris, 150 mmol/L NaCl, 1% Triton 
X-100 (Bio-Rad), 0.5% deoxycholate (Sigma) plus protease inhibitors cocktail 
(Roche), EDTA, and sodium vanadate (Sigma). Sample protein concentration was 
determined by the Protein Assay Reagent kit (Pierce). Whole cell lysates were 
separated by 12% SDS-PAGE and transferred to nitrocellulose. Blots were blocked 
with 5% nonfat milk at room temperature for 1 hour. Blots were incubated with the 
12 
 
p-Smad1/5/8 polyclonal antibody (1:1,000 dilution; Cell Signaling) and Smad 1/5/8/ 
polyclonal antibody (1:1,000 dilution; Santa Cruz) at room temperature with 
agitation for 1 hour, followed by incubation with anti-rabbit IgG horseradish 
peroxidase–conjugated antibody (1:2,000; GE Healthcare). Blots were developed 
using an enhanced chemiluminescence detection kit (ECL; Pierce). To confirm 
equal loading we used anti–β-actin antibody (1:5,000; Sigma).  Western Blots were 
quantified by densitometry analysis using Image J software (NIH).  
 
Whole mount in situ hybridization. 
We thank James Douglas Engel, Richard Maas, Robert E. Maxson Jr, Sylvia 
Evans and Stephen E. Harris for providing Gata3, Msx1, Msx2, Tbx20 and Bmp4 in 
situ probes.  Plasmids for in situ probes have been previously described: Dlx6 
(Charite et al., 2001), Gata3 (Ruest et al., 2004b), Hand1 (McFadden et al., 2005), 
Smad6 (Ma et al., 2005), Msx1 (Ishii et al., 2005) , Msx2 (Ishii et al., 2003), and 
Tbx20 (Shen et al., 2011).  Full-length cDNA for mouse BMP4 was provided by Dr. 
Stephen Harris and was linearized with SpeI and transcribe with T7.  Exon 3 and 4, 
including 3’UTR of Gadd45γ  were amplified and subcloned into T-easy vector.  
Plasmid was linearized with EcoRV and transcribe with T7 RNA polymerase.  Cux2 
(exon 23) and Satb2 (exon10) were amplified and subcloned into T-easy vector.  
Plasmid was linearized with SacI and transcribe with T7 RNA polymerase. 
Whole mount in situ hybridization were performed as follows:  embryos were 
fixed overnight in 10% formalin then dehydrated in 100% methanol overnight until 
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genotype were confirmed.  Embryos were re-hydrated in a graded series of 
methanol/PBS-Tween and treated with 10µl/ml of proteinase K for 15 minutes 
followed by 10 minute treatment with 2mg/ml glycine.  Before overnight probe 
hybridization at 70°C, embryos were fixed for 20 minutes with 4% 
paraformaldehyde.  Embryos were washed and pre-blocked with 10% sheep serum 
before overnight incubation with anti-Digoxigening-AP (Roche) at 4°C.  Additional 
washes were performed with TBST before detection with NBT/BCIP (Roche). For all 
experiments, at least three mutants and three controls embryos were analyzed for 
each probe. 
 
Quantitative Real Time PCR and Microarray.  
E11.5 mandibles were dissected in cold PBS and placed in RNAlater 
(Ambion) for RNA stabilization. mRNA was then extracted using the RNeasy Micro 
Kit (Qiagen).  First strand cDNA synthesis was then performed utilizing the 
SuperScript™ II Reverse Transcriptase kit (Invitrogen) with 500ng of mRNA. 
Quantitative Real-Time PCR was performed using SYBR Green QPCR Master Mix 
(Invitrogen) in triplicate reactions and ran on Mx3000P thermal cycler (Stratagene). 
Primers used in this study are listed in Appendix 2.  For all qRT-PCR experiments, 
at least three mutants and three control embryos were analyzed.  DNA microarray 
analysis, including gene ontology analysis, was performed using the OneArray™ 
Mouse Whole Genome Array (Phalanx Biotech Group).  Mandibular processes were 
pooled to collect a minimally required RNA amount: seven Bmp4 OE and five 
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controls embryos were used.  Gene ontology results were confirmed using DAVID 
Bioinformatics Resources 6.7 National Institute of Allergy and Infectious Diseases 
(NIAID), NIH. 
 
Chromatin immunoprecipitation. 
Chromatin immunoprecipitation (ChIP) analysis was performed as previously 
described (Wang et al., 2010).  We used E11.5 wild type mice mandibles and the 
mouse osteoblastic cell line MC3T3-E1 (ATCC).  Cells were maintained and 
propagated following ATCC protocols. Experiments were performed with 90% 
confluent cultures and Bmp4 (R&D System) was added to the media for a final 
concentration of 25pg/µl for 12hrs.  Primer sequences used for amplification of the 
Bmp/Smad regulatory elements are found in Apendix 2. 
 
Sequence analysis 
For sequence analysis and multiple sequence alignment, Ensembl genome 
database and MAFFT (http://mafft.cbrc.jp/alignment/server/) were used. 
15 
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Bmp2, Bmp4, and Bmp7 deletion in cranial neural crest results severe loss of 
cranial bone. 
We used the Wnt1cre driver and a Bmp4 conditional null allele, Bmp4floxneo to 
inactivate Bmp4 in CNC (Chai et al., 2000; Liu et al., 2004). Intercrosses between 
Wnt1cre; Bmp4 floxneo/+ with Bmp4floxneo homozygous mice generated Wnt1cre; 
Bmp4 floxneo;floxneo (f/f) mutant embryos, hereafter called Bmp4 CKO. Evaluation of 
skull preparations indicated that Bmp4 CKO mutant newborn skulls had enlarged 
frontal fontanelle and subtle mandibular defects (Fig. 4 A-B). Examination of Msx1 
and Msx2 expression, markers of preosteogenic head mesenchyme, revealed that 
these markers were reduced, but still present, in the Bmp4 CKO embryos (Fig. 3 A-
D).  Alkaline phosphatase, a marker of both preosteoblasts and mature osteoblasts, 
was also reduced in the frontal bone of Bmp4 CKO embryos, indicating a defect in 
the transition from pre-osteoblast to osteoblast in the Bmp4 CKO (Fig. 3 E-F).  
Persistent gene expression of downstream targets of the Bmp-signaling such as 
Msx gene in Bmp4 CKO embryos suggested that other Bmp ligands likely had 
overlapping functions with Bmp4 in CNC.  
To test this idea, we generated compound conditional loss of function 
mutants for Bmp2, Bmp4, and Bmp7 using the Wnt1cre driver.  Analysis of Bmp4 
and Bmp7 compound mutants indicated that Bmp7 failed to have a significant 
influence on Bmp4 CKO mutant phenotype (Fig. 4 A-E and 5 A). In contrast, Bmp2 
deletion in the Bmp4 CKO background resulted in significant worsening of frontal 
and mandibular bone phenotypes. The Bmp2/4 CKO mutant had a drastic reduction 
in most CNC-derivates bones, such as the frontal and mandible (Fig. 4 F-I and 5 B). 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Defects in osteoblast maturation in the absence of Bmp4. 
Msx1 (A-B) and Msx2 (C-D) expression pattern in controls and Bmp4 CKO 
embryos. Arrow denotes the expression of these genes in the frontal bone 
primordium at E12.5.  The Bmp4 CKO mutant has reduced expression of Msx1 (B) 
and Msx2 (D) in the frontal bone primordium compared to control. (E-F) Alkaline 
phosphatase staining of mature osteoblasts in control and Bmp4 CKO mutant at 
E14.5.  The Bmp4 CKO mutant frontal bone (arrow) is extremely reduced, though 
the parietal bone (arrowhead) is normal when compare to control.   f, frontal bone; 
p, parietal bone. 
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Figure 4.  Increased severity of craniofacial defects in Bmp compounds 
mutants.  
Alcian blue/alizarin red stains of E18.5 embryo showing defects in the frontal and 
mandible bone.  Arrow indicated the distance between the frontal bones use to 
measure the frontal fontanelle for each genotype.  a, angular process;  av, alveolar 
bone; c, coronoid process; co, condylar process; f, frontal bone;  ff, frontal 
fontanelle; n, nasal bone; p, parietal bone.  * indicates a p-value < 0.05, error bars 
represent SEM. 
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Figure 5.  Bmp4 and Bmp2 are the major ligands in frontal bone development. 
Bmp compounds mutants have an increase in the frontal fontanelle size when 
compare to littermate wildtype. 
20 
 
Additionally, Bmp2 had a unique role in coronoid process development (Fig. 4 G, K, 
N).  Analysis of triple mutant combinations further supported the conclusion that 
Bmp4 and Bmp2 were the major ligands in frontal and mandibular bone 
development.  Comparison between embryos that were Bmp2; Bmp4 compound 
homozygous and were either Bmp7+/+, Bmp7flox/+ or Bmp7flox/flox indicated that Bmp7 
has a minor role in frontal bone formation (Fig. 4 I, P and Q).  In addition to the 
frontal and mandibular bone defects, others CNC derivative bones were affected in 
Bmp compound mutants (Table 1). This genetic analysis indicated that while Bmp4 
was the major functional Bmp ligand in CNC-derived bone development Bmp2 also 
had important functions.  
 
Inducible over-expression of Bmp4 in the CNC  
A bacterial based, tetracycline inducible system was used to control the 
expression of Bmp4 in the cranial mesenchymal cells that give rise to the mandible 
and most midfacial bones (Chai and Maxson, 2006).   It has been shown that with 
this system the induction of tetracycline, or its analog doxycycline has low basal 
activity, high levels of inducibility and low toxicity. In addition, multiple studies have 
demonstrate that tetracycline and doxycycline cross the placenta, making this 
system valuable for developmental studies (Gossen et al., 1995; Shin et al., 1999). 
The tetracycline inducible system is a two-component system based on the E. 
Coli tet repressor. Two versions of this system exist, the original tTA and a modified  
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Table 1.  Bmp compounds mutant defects in the skeletal elements of the skull. 
Bone defects severity was scored as follows: 0, no change; 1, size reduction; 2, missing pieces and 3, missing bone.  
CP: cleft palate. 
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reverse Tet repressor, rtTA. In both systems, the tTA or rtTA fusion proteins are 
expressed in the cell type of interest by a tissue specific regulatory element 
(Gossen et al., 1995).  We used a conditional reverse tetracycline transcriptional 
activator allele generated at Dr. Andras Nagy laboratory (Mount Sinai Hospital, 
Canada). The allele has an rtTA coding sequence incorporated into the Rosa 26 
locus (Fig. 6 C). This allele is similar to the Rosa 26 reporter in that the rtTA is 
expressed only after removal of the LoxP flanked cassette that is dependent on cre 
recombinase activity (Belteki et al., 2005). In this system, rtTA protein binds to the 
tetracycline operator in the presence of the tetracycline analog, doxycycline (Fig. 6 
C). Upon binding to the tetracycline operator (TetO), the rtTA activates transcription 
of the tetracycline responder transgene. This binding is not permanent and in the 
absence of doxyclycline the transcription of the TetO responder gene stops. 
To investigate the role of elevated Bmp4-signaling in CNC, we developed a 
tetracycline-regulated Bmp4 allele (Bmp4TetO) by replacing the first non-coding exon 
and basal promoter region of Bmp4 with a tet operator Bmp4 cDNA fusion gene 
(Figure 6 A-B).  We used a cre-recombinase inducible rtTA (Tet-on) allele, 
R26RrtTANagy allele, and the Wnt1cre allele to induce rtTA in the CNC lineage. Bmp4 
was overexpressed by inducing Wnt1cre; Bmp4TetO; R26RrtTANagy (Bmp4 OE) 
embryos with doxycycline (dox).  
Next, we determined whether the Bmp4TetO allele directed significant levels of 
Bmp4 expression in the CNC lineage.  We treat the pregnant females with different 
concentration of dox in the drinking water for 24 hours.  We used mandible tissue of 
Bmp4 OE embryos and compared them to littermate embryos that possessed two  
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Figure 6.  A tetracycline regulated Bmp4 gain of function allele. 
(A) Targeting vector of Bmp4tetO allele, which contains the tetracycline operator 
(tetO7), CMV basal promoter, Bmp4 cDNA, IRES-lacZ and PGK-neo resistance 
cassette with two flanking Frt sites, targeted in Bmp4 basal promoter and Bmp4 
exon1.  (B) Clones were screened by Southern blot, showing correct targeting by a 
Spe1 digestion: the wild type band was 6.4 kb, the cDNA band was 11.7 kb, and the 
mutant allele was 8.0 kb.  (C) Schematic illustrating the strategy to regulate spatial 
and temporal expression of Bmp4 using the R26RrtTANagy allele (Belteki et al., 
2005). 
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wild type copies of the Bmp4 allele (Wnt1cre; R26RrtTANagy) as the control tissue.  
qRT-PCR analysis indicated that Bmp4 OE embryos had approximately 30-fold 
inducible Bmp4 upregulation. Furthermore, Bmp4 levels were increased with higher 
levels of dox (Figure 7 A).  We select the higher inducible dose of 2 mg/ml of dox for 
further experiments.  Next, we want to determine how quickly our system can 
induce transcription of Bmp4Teto allele. Bmp4 induction could be detected by qRT-
PCR 3 hours after dox induction and remained elevated through 24 hours of 
induction (Figure 7 B). Elevated Bmp4 was also detectable in CNC by whole mount 
in situ in E10.5 embryos after 24 hours of induction (Figure 7 C). Western blot 
indicated that the elevated Bmp4 mRNA expression resulted in about a 2.5-fold 
increase in p-Smad1/5/8 activity in the mandibular process revealing that negative 
regulatory mechanisms have a large impact on Bmp-signaling output (Figure 7 D).  
Therefore, we have been able to show that with this system we can control the 
spatial and temporal over-expression of Bmp4. 
  
Facial form is dramatically altered by elevated Bmp4 in CNC. 
We tested the phenotypic effects of elevated Bmp4 expression in the CNC by 
analyzing E16.5 Bmp4 OE embryos that had been induced at different embryonic 
stages. Bmp4 inductions starting at E13.5 caused a defect in the mandible 
development.  Mandibles were more pointed in appearance (Fig. 8 A-D), while this 
phenotype was intensified in the early induction (Fig. 8 D, H and L).  In addition to 
the size reduction of the mandible, when induction started at E11.5, Bmp4 OE 
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embryos showed open eyelids defects and a reduction in size of the whisker pad 
region (Fig. 8 E-F).  The most drastic change in facial appearance was observed in 
Bmp4 OE induced at E10.5. Besides the open eyelid phenotype, there was a 
shortening and pointed appearance in both the mandible and maxilla.  These 
embryos show undifferentiated epithelium in which the whisker pad is not 
recognizable (Fig. 8 I-J).  The overall shape of the head was more rounded as 
compared to control mouse embryo.  Moreover, the orientation of the eyes was 
more anterior as compared to the control (Fig. 8 D, H and L).  Induction at early time 
points resulted in open neural tube defects (data not shown).  These findings 
indicate that increasing Bmp4 levels regulated facial form in a stage-dependent 
fashion.  
Skeletal preparations at E16.5 indicated that Bmp4 induction starting at 
E10.5, resulted in strong reduction of rostral bony elements, such as nasal bones, 
with a drastically shortened face (Fig. 9 G, H). Overall bone quality was defective as 
revealed by multiple translucent areas in the skull bones. Bmp4 induction at E12.5 
had a less dramatic morphologic change, but the size of the nasal cartilages was 
expanded while nasal and frontal bones were absent or reduced (Fig. 9 E, F) and 
the mandible was shorter.  Induction at E13.5 revealed reduction in nasal bones 
and coronoid process of the mandible (Fig. 9 C, D) 
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Figure 7.  Overexpression of Bmp4 using doxycycline regulated system.   
(A) qRT-PCR of E11.5 mandibles showing the response of the Bmp4tetO allete to 
different concentration of doxycycline. (B) qRT-PCR of E11.5 mandibles showing 
the response of the Bmp4tetO allele to doxycycline at different periods of time.  (C) In 
situ hybridization showing total levels of Bmp4 transcript after 24 hrs of doxycycline 
(2mg/ml).  (D) Western blot and densitometry (n=3) analysis of E11.5 mandibles 
after 24 hrs of doxycycline (2mg/ml), 10ug protein/lane.  ** indicates a p-value < 
0.01, *** indicates a p-value < 0.001, error bars represent SEM. 
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Figure 8.  Morphological changes in the craniofacial region after Bmp4 over-
expression. 
Frontal and lateral views of control and Bmp4 OE embryos after the indicated 
induction period.  Arrows point at the morphologies changes in the mandible.   
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Figure 9.  Defective cranial bone ossification in the Bmp4 OE embryos.   
Lateral (A,C,E,G) and  top (B,D,F,H) view of E16.5 control (A-B) and Bmp4 OE 
embryos (C-H) after skeletal analysis.  Bmp4 induction started at different time 
points: E13.5 (C-D), E12.5 (E-F), and E10.5 (G-H).  a, angular process;  c, coronoid 
process; co, condylar process; f, frontal bone; ip, interparietal bone; m, mandible; 
mx, maxillary; n, nasal bone; p, parietal bone.   
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Figure 10.  Bmp4 OE embryos exhibit an expansion of the facial cartilage.  
H&E staining of E16.5 control (A-D) and Bmp4 OE embryos induced at E14.5 (E-H) 
and E12.5 (I-L).  Meckel’s cartilage is expanded in the Bmp4 OE embryos.  B, F and 
J are magnified view of dashed box in A, E and I, respectively.   The nasal cartilage 
is also expanded in the Bmp4 OE embryos.  D, H and J are magnified view of 
dashed box in C, G and K, respectively.  E, eye; I, incisor; MC, Meckel’s cartilage; 
T, tongue. * indicate the cleft palate phenotype.  
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Histologic analysis indicated that Bmp4 E12.5 induction resulted in a large 
increase in both nasal and Meckel’s cartilage indicating that Bmp4 modulates facial 
form by controlling both cartilage and bone development (Fig. 10 A-D, I-L). These 
Bmp4 E12.5 induced embryos also had cleft palate (Fig. 10 K). Embryos induced at 
E14.5 show milder phenotypes indicating that Bmp4 induced facial changes are 
stage dependent (Fig. 10 E-H).  These findings indicate that increasing Bmp4 levels 
regulated facial form in a stage-dependent fashion. 
 
Expression profiling uncovers transcriptional regulators that are upregulated 
in the mandible of Bmp4 gain of function embryos.  
To comprehensively investigate genes regulated by Bmp-signaling in the 
mandibular process, we performed a microarray analysis.  For this experiments, we 
used RNA extracted from mandibles of Bmp4OE and Wnt1cre; R26RrtTANagy control 
embryos that were induced with dox for 24 hours, starting at E10.5.  Using a 2-fold 
change (p< 0.05) as threshold, we identified 144 down-regulated and 120 up-
regulated genes (Fig. 11 A and Appendix 3).  Gene ontology analysis for all genes 
revealed several gene clusters involved in various cellular processes, such as 
nucleic acid metabolism, cellular biosynthesis, regulation of gene expression and 
transcription activity (Fig. 11 B).  Strikingly, among genes that were up-regulated 
after Bmp4 induction, gene ontology indicated that transcriptional regulation was the 
main cellular process influenced by upregulated Bmp-signaling (Fig. 11 C and 12 
A).   
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Figure 11. Differentially expressed genes in Bmp4OE mandibles.  
(A) Heat map showing 264 genes that were differentially expressed (>2-fold) in the 
Bmp4OE mandibles; 120 were up-regulated (pink), while 144 were down-regulated 
(blue).  (B) Gene Ontology analysis of 264 differentially expressed genes.  (C) Gene 
Ontology analysis of up-regulated genes. 
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Figure 12.  Bmp4 gain of function in the neural crest cells leads to up-
regulation of different transcriptional regulators.  
(A) Heat map representing 16 transcriptional regulators that were upregulated in 
Bmp4 OE mandibles (B) qRT-PCR validation of microarray results. Other genes 
from the same family were also included.  * indicates a p-value < 0.05, ** indicates a 
p-value < 0.01, *** indicates a p-value < 0.001, error bars represent SEM. 
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In order to confirm the microarray results, we used independently generated 
RNA from control and Bmp4 OE mandibles, and subjected them to qRT-PCR 
analysis.  Included in the Bmp4 induced genes (BIG) signature after qRT-PCR 
validation were multiple transcription factor families, including Gata genes, Hand 
genes, Satb genes and Klf genes (Fig. 12 B). Other upregulated transcriptional 
regulators include Atf3, Cux2, and Isl1.  Gata2, Hand2 and Satb2 are transcription 
factors that play important roles in craniofacial development (Barbosa et al., 2007; 
Dobreva et al., 2006; Ruest et al., 2004b).  Importantly, many of these genes (such 
as Isl1 and Id1) have been shown to be targets of Smad-mediated signaling in other 
developmental processes and many have known roles in craniofacial development 
(Korchynskyi and ten Dijke, 2002; Mitsiadis et al., 2003).  Interestingly, known 
negative regulators of Bmp-Smad signaling, Gadd45 and Smad6, and Noggin, were 
also strongly upregulated in the Bmp4 OE mandibles uncovering a negative 
feedback pathway in the mandible (Nohe et al., 2004; Suzuki et al., 2009).  
We further validated the microarray experiments by in situ hybridization 
analysis of the RNA transcripts.  In situ hybridization demonstrated an expanded 
expression pattern of the BIG signature after Bmp4 induction (Fig. 13 and 14).  
Interestingly, there were distinct upregulated gene expression patterns. Some 
genes, such as Hand1 and Smad6 were broadly expanded throughout the CNC 
whereas other genes, such as Gadd45γ and Satb2, were expanded in a more 
restricted region of the mandible (Fig. 13). 
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Figure 13.  Expanded expression pattern of the BIG signature after Bmp4 
induction. 
 
In situ hybridization on E11.5 embryos showing the change in the expression 
pattern of the indicated genes in the Bmp4 OE. 
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Figure 14.  Expression patterns of up-regulated genes in Bmp4OE embryos. 
In situ hybridization on E11.5 controls and Bmp4OE embryos, showing the change 
in the expression pattern of the indicated genes. 
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Figure 15.  Bmp deficiency results in reduced mandibular expression of Bmp-
regulated genes.  (A) qRT-PCR of E11.5 control and Nkx2.5cre;Bmp4 CKO 
mandibles.  (B) In situ hybridization on E11.5 embryos showing the change in the 
expression pattern of the indicated genes in the Nkx2.5cre;Bmp4 CKO.  * indicates a 
p-value < 0.05, ** indicates a p-value < 0.01, *** indicates a p-value < 0.001, error 
bars represent SEM. 
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Common target genes that are expanded in the Bmp4 OE embryos are also 
downregulated in Bmp loss of function embryos.  
To determine whether the same sets of genes that are upregulated in the 
Bmp4 OE embryos were also reduced in the Bmp loss of function embryos, we 
evaluated the expression of the candidate genes in response to decreased Bmp- 
Smad activity.  Because the Wnt1cre; Bmp2/4/7 triple mutants are recovered at low 
frequencies, we supplemented our experiments with the Nkx2.5cre; Bmp4n/f embryos 
that have greatly reduced Bmp-signaling in the mandibular ectoderm and 
mesenchyme (Liu et al., 2005a). qRT-PCR analysis of the mandibular tissue 
showed significant reduction in the expression levels of genes that were up-
regulated in the Bmp4 OE tissue (Fig. 15 A).  Moreover, whole mount in situ 
analysis for a subset of these genes revealed loss of mandibular expression in 
Bmp4 mutant embryos (Fig. 15 B). 
 
Subsets of transcriptional regulators are direct Bmp4 targets.  
The up-regulation of Gadd45γ, Gata3, Hand1, Satb2 and Smad6 transcripts 
in a cell environment rich in Bmp4 signaling, as well as, their down-regulation in the 
absence of Bmp4 (Fig. 13 and Fig. 15 B), give rise to the possibility that these 
genes are direct targets of Bmp4 signaling.  To determine whether these BIG 
signature genes were directly regulated by Smad-mediated transcription, we 
undertook a bioinformatic approach to identify conserved Smad recognition 
elements within a 5Kb region located in the 5’ flanking region of these genes. For 
38 
 
Gadd45γ, Gata3, Hand1, Satb2 and Smad6, we uncovered phylogenetically 
conserved Smad recognition elements (Fig. 16 A). We tested the ability of Smad1/5 
to bind to these sequences in vivo by ChIP assays in wild-type mandibles and in the 
mouse osteoblastic cell line, MC3T3-E1.  Our data indicate that in the developing 
mandible, Smad1/5 binds directly to the chromatin of these five genes (Fig. 16 B).  
Moreover, in MC3T3-E1 cells that were cultured in the presence of Bmp4, we found 
an increased enrichment in Smad1/5 chromatin binding after Bmp treatment (Fig. 
16 C).   
39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Direct, Smad-mediated regulation of a subset of Bmp-induced 
genes.   
(A) Sequence alignment showing the conservation among species of the putative 
Smad1 binding site.  ChIP assay using (B) E11.5 wild-type mandibles and (C) 
MC3T3-E1 cells culture for 12 hrs in the absent or presence of 25pg/ul of Bmp4.  
(D) Bmp regulates craniofacial skeletal development by balancing self-renewal and 
differentiation in the CNC progenitors 
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 We performed a comprehensive analysis of Bmp function in CNC using 
genetics, gene expression profiling, and ChIP. Our profiling and qRT-PCR validation 
data from the Bmp4 OE embryos indicate that the BIG signature contains twenty-
one genes.  Moreover, we validated seventeen of the twenty-one genes in the Bmp 
loss of function model revealing that Bmp is necessary and sufficient for expression 
of those seventeen genes. 
Our data reveal that Bmp controls bone morphogenesis and facial form via 
common target genes.  The BIG signature was upregulated in Bmp4 OE embryos 
with facial form changes and reduced in Bmp deficient embryos with severe bone 
morphogenesis phenotypes. Within the BIG signature are transcriptional regulators 
important for osteoblast differentiation and progenitor cell self-renewal. Bmp-
signaling also induces a negative regulatory pathway that likely functions as a 
buffering mechanism to maintain precise Bmp-signaling levels. We show that six 
genes, Gata3, Gadd45γ, Hand1, Satb2, and Smad6, are directly bound by Smad 
1/5. Our findings indicate that a balance between self-renewal and progenitor 
differentiation in CNC underlies Bmp-regulated facial form control and bone 
morphogenesis (Figure 16 D).  
 
Direct Bmp target genes regulate cranial neural crest progenitor self-
renewal.  
Our data show that Bmp-signaling in CNC progenitors regulates genes that 
are directly implicated in self-renewal such as Id and Klf genes. Klf2 and Klf5, as 
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well as Id1 and Id4 are regulated by Bmp-signaling in CNC progenitors.  Klf genes, 
regulators of ES cell self-renewal by controlling Nanog expression and cellular 
reprogramming, have not been shown to be regulated by Bmp-signaling (Zhang et 
al., 2010). Our findings suggest that Bmp-signaling in CNC promotes limited self-
renewal of CNC cells that allow progenitor cells to persist for a short time as 
craniofacial development progresses.  
In other in vivo model systems, such as the Drosophila ovary, Bmp signaling 
promotes self-renewal and proliferation of somatic stem cells and prolongs 
progenitor lifespan (Kirilly et al., 2005). In CNC progenitors, it is conceivable that 
Bmp-signaling increases the number of self-renewing progenitor cells in addition to 
activating expression of the CNC self-renewal program. 
In addition to inducing Id1 expression in embryonic stem cells, Bmp-signaling 
directly promotes self-renewal in collaboration with leukemia inhibitory factor 
through a direct interaction between Smad1 and the core self-renewal factors 
Nanog, Oct4 and Sox2  (Chen et al., 2008; Fei et al., 2010; Ying et al., 2003). As 
defined by ChIP seq, Smad1 commonly occupies Nanog-Oct4-Sox2 bound loci 
revealing that Bmp-signaling directly interacts with the core pluripotency machinery 
to enhance pluripotency and self-renewal. Moreover, the Smad1-containing 
complexes in ES cells recruit the HAT p300 to activate gene transcription (Chen et 
al., 2008).  Our findings support a model in which Bmp-signaling enhances CNC 
progenitor self-renewal by activating the self-renewal gene program. Future ChIP 
seq experiments will be required to determine if Smad1 directly interacts with a 
pluripotency program in CNC progenitors. 
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Bmp promotes osteoblast differentiation from CNC progenitors. 
Bmp-signaling also regulates lineage-restricted genes such as Satb2 that 
enhance osteoblast lineage development. Satb2 is a DNA binding and architectural 
factor that has a positive role in osteoblast development.  Satb2 deficiency results in 
phenotypes that are similar to mild Bmp loss of function phenotypes such as cleft 
palate and calvarial defects with shortened mandible. Importantly, Satb2 controls 
osteoblast differentiation through regulation of Runx2 and Atf4 expression (Dobreva 
et al., 2006). Notably, similar to Bmp4, Satb2 deficiency causes orofacial clefting in 
humans as well as mice (Britanova et al., 2006). Our data shows that Satb2 is a 
direct Smad1/5 target indicating that a major pathway for Bmp-regulated bone 
development and facial form regulation is through Satb2 function.  
Similar to Bmp4 loss of function mutants, Gata3 mutants have a medial 
mandibular deficiency (Liu et al., 2005a; Ruest et al., 2004a). There is evidence that 
Gata3 directly regulates N-myc in the branchial arches suggesting that one cellular 
mechanism in the Gata3 mutant mandible is reduced proliferation (Potvin et al., 
2010). Other data also indicate that Gata3 promotes osteoblast and neuron survival 
suggesting that in addition to proliferation, apoptosis may also be enhanced in 
Gata3 mutants as it is in Bmp4 loss of function embryos (Chen et al., 2010; Liu et 
al., 2005a; Tsarovina et al., 2010).   
Hand1 and Hand2 have overlapping function in medial mandible 
development, and promote progenitor cell proliferation and inhibit differentiation 
(Barbosa et al., 2007; Funato et al., 2009). In the heart, Hand1 overexpression 
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increases cell proliferation indicating that the Hand mandibular defect may result 
from reduced progenitor cell proliferation. It is interesting to note that both Hand1 
and Gata3 have been implicated in trophoblast development indicating that these 
two genes may have interrelated functions in multiple cellular contexts (Ralston et 
al., 2010).  
In addition to Bmp-signaling, the Endothelin (Edn) signaling pathway 
regulates Hand gene expression and also is critically important in facial form 
regulation.  Edn deficient embryos display mandibular to maxillary transformations 
that are restricted to the Hox negative CNC (Gitton et al., 2010). Moreover, gain of 
function experiments indicate that expanded Edn and Hand2 in maxillary process 
results in transformation to a mandibular phenotype. Our data indicate that Bmp and 
Edn-signaling converge on Hand gene function to regulate facial form.   
The Dlx 5/6 genes, targets for Edn-signaling and direct regulators of Hand2, 
are also critically important in facial form development (Depew et al., 2002). Only 
modest Dlx6 expansion in Bmp4 OE embryos indicate that Bmp induced regulation 
of Hand genes primarily goes directly through Smad 1/5 (Fig. 14).  
 
Bmp-regulated negative feedback loops are critical for mandible development 
Negative auto-regulation is a mechanism to confer robustness to the 
developing embryo by buffering the system from elevated Bmp levels and is critical 
for normal craniofacial and heart development (Paulsen et al., 2011; Prall et al., 
2007). Bmp4 induced expression of genes that are negative regulators of Bmp-
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signaling such as Smad6, Noggin, and Gadd45. The importance of finely tuned 
Bmp-signaling levels in mice and humans is apparent from Noggin loss of function 
studies in mice as well as human genetics studies. Noggin deficiency results in cleft 
palate, defective mandibular development, as well as limb and heart defects (Brunet 
et al., 1998; Choi et al., 2007; Gong et al., 1999; He et al., 2010). The negative 
auto-regulatory pathway includes two genes, Gadd45γ and Smad6 that are Smad-
regulated direct Bmp targets. Moreover, the negative auto-regulatory pathway 
modulates the pathway by multiple mechanisms. Smad6 inhibits R-Smad activity by 
both competing for Smad4 and also inhibiting R-Smad phosphorylation. Gadd45γ 
promotes ubiquitin ligase interaction with the Smad linker region to destabilize R-
Smad, while Noggin is a competitive inhibitor of the Bmp ligand-receptor interaction 
(Sheng et al., 2010).  
 
Bmp-signaling controls expression of multiple families of transcriptional 
regulators  
Cux2 has not been previously connected to Bmp-signaling or bone 
morphogenesis. The closely related gene, Cux1, is regulated by Tgf-β and 
represses collagen expression. Cux2 is regulated by Notch in the spinal cord where 
it controls cell cycle progression and promotes interneuron fate.  Cux2 also has 
been shown to regulate dendrite morphology in post-natal brain (Iulianella et al., 
2009; Iulianella et al., 2003). 
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Among the other Bmp-regulated genes that we identified, are genes that 
were previously shown to be Bmp-regulated. Previous experiments uncovered a 
Bmp-Msx genetic pathway in multiple contexts within the developing craniofacial 
apparatus including skull, palate and teeth (Chai and Maxson, 2006). Our data also 
indicate that Isl1 is regulated by Bmp-signaling during mandibular development. 
There is evidence that Bmp and Isl1 function in a positive feedback loop in the 
mandible (Mitsiadis et al., 2003). Our data support these earlier findings and 
substantially extend previous understanding of Bmp targets in craniofacial 
development. 
 
Future direction 
Our in situ data indicate that in the Bmp4 OE embryos one gene group 
including Gata3, Hand1, and Smad6 was broadly expressed throughout the cranial 
neural crest in response to Bmp4 overexpression. In contrast, genes such as Satb2 
and Gadd45γ were more resistant to Bmp4 overexpression and were upregulated in 
a more discrete spatial pattern.  This observation exposes the possibility of other 
regulatory mechanisms capable of fine-tune the expression of Satb2 and Gadd45γ. 
miRNA are small non-coding RNAs that post transcriptionally regulate gene 
expression by enhancing mRNA degradation or by inhibiting translation (Bartel, 
2009).  Recently studies show the participation of Bmp induced Smad signaling 
activity during the transcription of microRNA (miRNA).  It has been revealed 
capability of Smad1/5 to directly bind to the Drosha complex to promote microRNA 
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(miR) processing (Davis et al., 2008). Furthermore, our group has shown that Bmp-
signaling can induce miR transcription through a canonical Smad regulated 
mechanism (Wang et al., 2010). 
To test the possible involving of miRNA in the Bmp4 OE embryos 
phenotypes, we can simultaneous induce heterozygosity of Dicer in the Bmp4 OE 
embryos (Wnt1cre; Bmp4teto; R26Nagy+/-; Dicerf/+).  If the elevated levels of Bmp4 
observed in the Bmp4 OE embryos are triggering a miRNA activation pathway, 
heterozygosity of Dicer should suppress some of the phenotype observed in the 
Bmp4 OE embryos. 
One idea is that other signaling pathways, such as Wnts, may regulate miR 
expression that then degrades target mRNAs in certain domains of the branchial 
arches. Alternatively, the distinct responses to Bmp4 signaling may be regulated at 
the level of chromatin regulation such that Smad mediated activation is offset by 
negative regulatory mechanisms that cannot be overcome by high levels of Bmp-
signaling.   
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Appendix 1.  Bmp2, Bmp4, and Bmp7 conditional null alleles.
51 
 
Appendix 2.  Primers sequence for qRT-PCR and ChIP experiments. 
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Appendix 3.  List of statistically significant genes that were differentially 
expressed in the mandible after Bmp4 over-expression. 
 
 
probe id 
Bmp4 OE vs 
Control 
(FoldChange) 
Bmp4 OE vs 
Control (Pvalue) 
Ensembl 
Gene 
Symbol Ensembl Gene Description 
mMC004687 -13.1 0.0004 Cbln4 Cerebellin-4 precursor.  
mMC004895 -12.75 0.0021 Osr2 Protein odd-skipped-related 2. 
mMC007461 -8.88 0.0002 Barx1 Homeobox protein BarH-like 1.  
mMC001824 -7.55 0.0017 Shox2 Short stature homeobox protein 2. 
mMC006410 -7.53 0.0026 Smoc1 
SPARC-related modular calcium-binding protein 1 
precursor 
mMC011279 -7.26 0.0023 Smoc2 
SPARC-related modular calcium-binding protein 2 
precursor  
mMC013934 -7.25 0.0032 Meox2 Homeobox protein MOX-2. 
mMR028474 -6.55 0.0029 Cyp1b1 Cytochrome P450 1B1. 
mMC018294 -6.15 0.0016 Bnc1 Zinc finger protein basonuclin-1.  
mMR028929 -5.25 0.0017 Tbx15 T-box transcription factor TBX15. 
mMC001020 -5.1 0.0093 Osr1 Protein odd-skipped-related 1. 
mMC002854 -4.87 0.0004 Crlf1 Cytokine receptor-like factor 1 precursor. 
mMC023938 -4.72 0.0132 Pax1 Paired box protein Pax-1.  
mMC005050 -4.66 0.0006 Prr6 Proline-rich protein 6. 
mMC004704 -4.42 0.0031 Wnt2 Protein Wnt-2 precursor. 
mMC017469 -4.26 0.0035 Dkk4 Dickkopf-related protein 4 precursor. 
mMC024318 -4.23 0.0004 Angptl1 Angiopoietin-related protein 1 precursor. 
mMC001087 -4.18 0.006 Has2 Hyaluronan synthase 2. 
mMC006133 -4.08 0.0041 Aldh1a2 Retinal dehydrogenase 2. 
mMC012585 -4.08 0.0026 Cyp26a1 Cytochrome P450 26A1. 
mMC023854 -4 0.026 Eya4 Eyes absent homolog 4. 
mMC011362 -3.95 0.0004 Sfrp2 Secreted frizzled-related protein 2 precursor. 
mMR028699 -3.89 0.0152 Birc5 Baculoviral IAP repeat-containing protein 5. 
mMC020668 -3.78 0.0002 Tgfbr3 TGF-beta receptor type III precursor. 
mMC010520 -3.75 0.0011 Prdx2 Peroxiredoxin-2. 
mMC006582 -3.73 0.0013 Thy1 Thy-1 membrane glycoprotein precursor. 
mMR026812 -3.61 0.0178 Cdk5r1 Cyclin-dependent kinase 5 activator 1 precursor. 
mMC011387 -3.6 0.0009 Tbc1d2 TBC1 domain family, member 2. 
mMC004686 -3.57 0.0017 Irx2 Iroquois-class homeodomain protein IRX-2. 
mMR027206 -3.44 0.0008 Spp1 Osteopontin precursor (Bone sialoprotein 1) 
mMC014693 -3.32 0.0079 Bnc2 Zinc finger protein basonuclin-2. 
mMC012271 -3.27 0.0028 Col8a1 Collagen alpha-1(VIII) chain precursor.  
mMC015778 -3.12 0.0075 Mkx Homeobox protein Mohawk.  
mMC009536 -3.09 0.0041 Adora2b Adenosine receptor A2b. 
mMC009633 -3.07 0.0065 Pax3 Paired box protein Pax-3. 
mMC007876 -3.06 0.0029 Ddit4l DNA-damage-inducible transcript 4-like protein. 
mMC005287 -3.01 0.0032 Etv5 ETS translocation variant 5. 
mMC020953 -3 0.0048 Sfrp1 Secreted frizzled-related protein 1 precursor (sFRP-1).  
mMC004112 -3 0.0043 Mmd2 Monocyte to macrophage differentiation factor 2. 
mMC011604 -2.99 0.0068 Twist2 Twist-related protein 2  (Dermo-1).  
mMC012120 -2.99 0.0003 Ccne1 G1/S-specific cyclin-E1.  
mMC016088 -2.92 0.0044 Hey2 Hairy and enhancer of split-related protein 2. 
mMC016113 -2.88 0.0048 Emx2 Homeobox protein EMX2 (Empty spiracles homolog 2). 
mMC024238 -2.87 0.0006 Hoxd8 Homeobox protein Hox-D8 (Hox-4.3) (Hox-5.4). 
mMC011610 -2.87 9.35E-05 Lingo2 leucine rich repeat and Ig domain containing 2. 
mMC019146 -2.84 0.0079 Tnc Tenascin precursor (TN) (Tenascin-C). 
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mMR027081 -2.84 0.0011 Jarid1d Histone demethylase JARID1D. 
 
 
 
probe id 
Bmp4 OE vs 
Control 
(FoldChange) 
Bmp4 OE vs 
Control (Pvalue) 
 Ensembl 
Gene 
Symbol Ensembl Gene Description 
mMC005059 -2.81 0.0046 Kif4 Chromosome-associated kinesin KIF4 (Chromokinesin).  
mMC014576 -2.78 0.0043 Agtr1a Type-1A angiotensin II receptor (AT1) (AT1A).  
mMC011224 -2.76 0.0003 Lhx8 LIM/homeobox protein Lhx8. 
mMC016964 -2.76 0.0005 Mxd3 Max-interacting transcriptional repressor MAD3. 
mMR029106 -2.76 1.90E-05 Tbx18 T-box transcription factor TBX18 (T-box protein 18).  
mMC025853 -2.75 0.0072 Col23a1 Collagen alpha-1(XXIII) chain.  
mMC007337 -2.72 0.0151 Acadm Medium-chain specific acyl-CoA dehydrogenase. 
mMC006073 -2.63 0.0047 Nt5e 5'-nucleotidase precursor. 
mMR027782 -2.63 0.0014 Tcfap2c Transcription factor AP-2 gamma (AP2-gamma). 
mMC007882 -2.6 0.0025 Phf17 Protein Jade-1 (PHD finger protein 17).  
mMC013088 -2.58 0.0091 Calca Calcitonin gene-related peptide 1 precursor. 
mMC021257 -2.57 0.0104 Bub1 Mitotic checkpoint serine/threonine-protein kinase BUB1 . 
mMR027630 -2.56 0.0019 Ccnd1 G1/S-specific cyclin-D1. 
mMR027330 -2.55 0.0194 Fgf10 Fibroblast growth factor 10 precursor. 
mMC023785 -2.54 0.0083 Lhx9 LIM/homeobox protein Lhx9. 
mMC015557 -2.53 0.0007 Col27a1 Collagen alpha-1(XXVII) chain precursor.  
mMC011218 -2.52 0.0004 Fanci Fanconi anemia group I protein homolog. 
mMC005685 -2.51 0.0019 Dlx1 Homeobox protein DLX-1.  
mMC004336 -2.51 0.0115 Recql4 ATP-dependent DNA helicase Q4. 
mMC020644 -2.5 0.0131 Bok Bcl-2-related ovarian killer protein (Matador protein). 
mMC002917 -2.5 0.0033 Epha3 Ephrin type-A receptor 3 precursor. 
mMR029325 -2.48 0.0016 Col6a3 Collagen alpha3(VI) precursor (Fragment). 
mMC024692 -2.47 0.0031 Ccnd1 G1/S-specific cyclin-D1. 
mMR030518 -2.46 0.002 Ddx3y ATP-dependent RNA helicase DDX3Y. 
mMC010000 -2.46 0.0028 Wnt9a Protein Wnt-9a precursor (Wnt-14).  
mMR026292 -2.43 0.0107 Nfatc1 Nuclear factor of activated T-cells, cytoplasmic 1.  
mMC021250 -2.42 0.0051 Pitx1 Pituitary homeobox 1 (Homeobox protein P-OTX). 
mMC016640 -2.4 0.0388 Pola1 DNA polymerase alpha catalytic subunit. 
mMC016646 -2.39 0.0067 Egfr Epidermal growth factor receptor precursor. 
mMC009648 -2.39 0.0006 Bmp7 Bone morphogenetic protein 7 precursor. 
mMC013663 -2.39 0.0118 Tnmd 
Tenomodulin (TeM) (mTeM) (Chondromodulin-I-like 
protein). 
mMC003890 -2.38 0.0064 Crabp2 Cellular retinoic acid-binding protein 2.  
mMC008043 -2.37 0.0204 Chek1 Serine/threonine-protein kinase Chk1. 
mMC004121 -2.36 0.0066 Spc24 Kinetochore protein Spc24. 
mMR029934 -2.35 0.0017 Cdc6 Cell division control protein 6 homolog. 
mMR029574 -2.33 0.0004 Bmpr1b Bone morphogenetic protein receptor type IB precursor. 
mMC002759 -2.31 0.027 Rad51 DNA repair protein RAD51 homolog 1.  
mMC010318 -2.31 0.0165 Foxd1 Forkhead box protein D1. 
mMC008299 -2.31 0.0111 Efemp1 EGF-containing fibulin-like extracellular matrix protein 1. 
mMC019230 -2.29 0.0291 Tbx15 T-box transcription factor TBX15. 
mMC005043 -2.29 0.0052 Twist1 Twist-related protein 1 (M-twist). 
mMR027407 -2.28 0.0203 Ddx3y ATP-dependent RNA helicase DDX3Y. 
mMC004631 -2.27 0.0059 Lmcd1 LIM and cysteine-rich domains protein 1. 
mMC025368 -2.27 0.0022 Cdc20 Cell division cycle protein 20 homolog. 
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mMC023569 -2.26 0.0074 Cdc6 Cell division control protein 6 homolog. 
mMR028442 -2.26 0.0331 Dtl Denticleless protein homolog. 
mMC022184 -2.26 0.0013 Gtse1 G2 and S phase-expressed protein 1. 
mMR028305 -2.24 0.0155 Lhx8 LIM/homeobox protein Lhx8. 
 
probe id 
Bmp4 OE vs 
Control 
(FoldChange) 
Bmp4 OE vs 
Control (Pvalue) 
 Ensembl 
Gene 
Symbol Ensembl Gene Description 
mMC018720 -2.24 0.0006 Eya2 Eyes absent homolog 2. 
mMC020210 -2.23 0.0025 Spon1 Spondin-1 precursor (F-spondin).  
mMC010627 -2.22 0.0124 Gbx2 Gastrulation and brain-specific homeobox protein 2. 
mMC018217 -2.22 0.0063 Cenpn Centromere protein N (CENP-N).  
mMC006090 -2.22 0.0319 Wbp11 WW domain-binding protein 11 (WBP-11). 
mMC003963 -2.21 0.0163 Fap Seprase (Fibroblast activation protein alpha). 
mMC010387 -2.2 0.025 Spry2 Protein sprouty homolog 2. 
mMC006225 -2.2 0.0012 Aurka Serine/threonine-protein kinase 6  (Aurora kinase A). 
mMC022453 -2.19 0.0265 Fgf10 Fibroblast growth factor 10 precursor. 
mMC012277 -2.19 0.0462 Mns1 Meiosis-specific nuclear structural protein 1. 
mMC006899 -2.18 0.0384 Brca1 Breast cancer type 1 susceptibility protein homolog.  
mMR029214 -2.18 0.0297 Smc2 Structural maintenance of chromosomes protein 2. 
mMC022196 -2.18 0.0039 Col23a1 Collagen alpha-1(XXIII) chain.  
mMC014446 -2.17 0.043 Incenp Inner centromere protein. 
mMC006074 -2.16 0.0034 Xrcc3 X-ray repair cross-complementing protein 3. 
mMC014443 -2.15 0.0033 Cdc25c M-phase inducer phosphatase 3. 
mMR028076 -2.15 0.007 Barx2 Homeobox protein BarH-like 2.  
mMC016874 -2.14 0.0018 Sgol2 Shugoshin-like 2. 
mMC012062 -2.14 0.0075 Hist1h2ao Histone H2A type 1.  
mMC009891 -2.13 0.0012 Spc25 Kinetochore protein Spc25.  
mMC017517 -2.13 0.0049 Mlf1 Myeloid leukemia factor 1 . 
mMC009710 -2.13 0.035 Bard1 BRCA1-associated RING domain protein 1 (BARD-1).  
mMC014769 -2.13 0.0117 Rarb Retinoic acid receptor beta (RAR-beta). 
mMC007490 -2.11 0.0023 Dcp2 mRNA-decapping enzyme 2. 
mMC003317 -2.11 0.0287 Ercc6l excision repair cross-complementing group 6 - like. 
mMR030048 -2.11 0.008 Wnt5a Protein Wnt-5a precursor. 
mMC006771 -2.11 0.0115 Eml3 
Echinoderm microtubule-associated protein-like 3 
(EMAP-3). 
mMC007743 -2.11 0.0096 Ccnb2 G2/mitotic-specific cyclin-B2.  
mMC014831 -2.1 0.0026 Hist1h1b Histone H1.5 (H1 VAR.5) (H1b).  
mMR026709 -2.1 0.0277 Mbnl3 Muscleblind-like X-linked protein 3. 
mMC017313 -2.1 0.0317 Gas2 Growth arrest-specific protein 2. 
mMR028181 -2.09 0.0002 Timp3 Metalloproteinase inhibitor 3 precursor. 
mMC002529 -2.08 0.0265 Bcl2 Apoptosis regulator Bcl-2. 
mMC011122 -2.08 0.0339 Cebpz CCAAT/enhancer-binding protein zeta. 
mMC022135 -2.08 0.0012 Plk1 Serine/threonine-protein kinase PLK1. 
mMC017102 -2.07 0.0205 Cdca2 Cell division cycle-associated protein 2. 
mMC022855 -2.07 0.0006 Ccnb1 G2/mitotic-specific cyclin-B1. 
mMC014639 -2.05 0.0099 Pold2 DNA polymerase subunit delta-2. 
mMC005065 -2.05 0.0194 Rbm8a RNA-binding protein 8A. 
mMC004902 -2.05 0.0254 Pif1 ATP-dependent DNA helicase PIF1. 
mMR029647 -2.03 0.0053 Lix1 Protein limb expression 1 homolog. 
mMR027721 -2.03 0.0234 Col8a2 
Collagen alpha-2(VIII) chain precursor, Endothelial 
collagen. 
mMR028184 -2.03 0.0047 Gas2 Growth arrest-specific protein 2 (GAS-2). 
mMC016105 -2.03 0.0381 Six2 
Homeobox protein SIX2 (Sine oculis homeobox homolog 
2). 
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mMC018871 -2.01 0.0042 Cenpm Centromere protein M. 
mMC005713 -2.01 0.0377 Cenpf centromere protein F. 
mMR026745 -2.01 0.0026 Tcfap2b Transcription factor AP-2 beta. 
mMC001743 -2 0.0044 Has3 Hyaluronan synthase 3. 
mMC026007 -2 0.0099 Suv39h2 Histone-lysine N-methyltransferase SUV39H2. 
 
 
probe id 
Bmp4 OE vs 
Control 
(FoldChange) 
Bmp4 OE vs 
Control (Pvalue) 
 Gene 
Symbol Ensembl_Gene_Description 
mMR030652 2 0.0194 Socs2 Suppressor of cytokine signaling 2. 
mMC025149 2.01 0.0474 Olfr282 olfactory receptor 282. 
mMC007940 2.01 0.0002 Msx1 Homeobox protein MSX-1 (Msh homeobox 1-like protein). 
mMC016067 2.02 0.0183 Smyd1 SET and MYND domain-containing protein 1. 
mMC014229 2.03 0.0083 Meis2 Homeobox protein Meis2 (Meis1-related protein 1). 
mMC011307 2.05 0.0235 Mafb Transcription factor MafB. 
mMC021817 2.05 0.0149 Il18 Interleukin-18 precursor. 
mMC014455 2.05 0.0223 Hao3 Hydroxyacid oxidase 2. 
mMC024996 2.06 0.0208 Ehmt1 euchromatic histone methyltransferase 1 isoform 1 . 
mMC004022 2.06 0.0174 Med17 Mediator of RNA polymerase II transcription subunit 17. 
mMC012216 2.07 0.0058 Gpr50 
Melatonin-related receptor (G protein-coupled receptor 
50). 
mMC008429 2.08 0.002 Guca1b Guanylate cyclase activator 1B.  
mMC017691 2.09 0.0123 Tle2 Transducin-like enhancer protein 2. 
mMC006701 2.09 0.0489 Olfr552 olfactory receptor 552. 
mMC004293 2.09 0.0103 Adh1 Alcohol dehydrogenase 1. 
mMC018176 2.1 0.0476 Art2b T-cell ecto-ADP-ribosyltransferase 2 precursor. 
mMR030084 2.1 0.0053 Igfbp5 Insulin-like growth factor-binding protein 5 precursor. 
mMC024704 2.11 0.0171 Olfr1102 Olfactory receptor 1102. 
mMC006134 2.12 0.0389 Isl2 Insulin gene enhancer protein ISL-2 (Islet-2).  
mMC004625 2.12 0.0033 Gpr19 Probable G-protein coupled receptor 19. 
mMR029458 2.13 0.0141 Tgfb1i1 Transforming growth factor beta-1-induced transcript 1. 
mMC018508 2.13 0.0469 Taok3 Serine/threonine-protein kinase TAO3. 
mMC006059 2.13 0.024 Spink5 serine peptidase inhibitor, Kazal type 5. 
mMR027435 2.13 0.0047 Col24a1 procollagen, type XXIV, alpha 1. 
mMC012387 2.13 0.0129 Tle6 Transducin-like enhancer protein 6. 
mMR030613 2.14 0.0234 Gria2 Glutamate receptor 2 precursor. 
mMC018518 2.14 0.042 Gprc5d G-protein coupled receptor family C group 5 member D. 
mMC005104 2.15 0.0051 Sox5 Transcription factor SOX-5.  
mMC001008 2.16 0.0215 Efna1 
Ephrin-A1  (EPH-related receptor tyrosine kinase ligand 
1). 
mMC012578 2.16 0.0219 Hspa2 Heat shock-related 70 kDa protein 2. 
mMC018772 2.17 0.0002 Gprin3 G protein-regulated inducer of neurite outgrowth 3. 
mMC022310 2.19 0.0265 Pafah1b2 Platelet-activating factor acetylhydrolase IB subunit beta. 
mMC025035 2.19 0.0133 Elmo1 Engulfment and cell motility protein 1 (CED-12 homolog). 
mMC002788 2.21 0.025 Msr2 macrophage scavenger receptor 2. 
mMR028041 2.22 0.0089 Serf1 Small EDRK-rich factor 1 (4F5) (m4F5). 
mMC007974 2.23 0.0252 Spsb1 SPRY domain-containing SOCS box protein 1 (SSB-1). 
mMC025800 2.24 0.0004 Unc13b Protein unc-13 homolog B (Munc13-2). 
mMC003788 2.24 0.0036 Prrx2 Paired mesoderm homeobox protein 2. 
mMC008313 2.24 0.0275 Map3k1 Mitogen-activated protein kinase kinase kinase 1. 
mMR030964 2.24 0.0286 Ptgs2 Prostaglandin G/H synthase 2 precursor. 
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mMC019189 2.25 0.0051 Olfr459 olfactory receptor 459. 
mMR028863 2.25 0.0015 Klf5 Krueppel-like factor 5. 
mMC018573 2.26 0.0378 Olfr411 olfactory receptor 411. 
mMR030035 2.26 0.0096 Satb1 Special AT-rich sequence-binding protein 1. 
mMC013645 2.26 0.0033 Alcam CD166 antigen precursor. 
mMC023971 2.28 0.0203 Pmp22 Peripheral myelin protein 22. 
mMC007194 2.3 0.0177 Cd1d1 T-cell surface glycoprotein CD1d1 precursor. 
mMC004741 2.31 0.0033 Skil Ski-like protein. 
mMC009330 2.31 0.0366 Olfr651 olfactory receptor 651. 
mMC007674 2.32 0.0198 Mypn Myopalladin. 
mMC021286 2.34 0.0188 Actg1 Actin, cytoplasmic 2 (Gamma-actin).  
mMC020398 2.34 0.0064 Krt8 Keratin, type II cytoskeletal 8. 
mMC006869 2.36 0.0315 Spon2 Spondin-2 precursor (Mindin). 
mMR029558 2.39 0.0045 Rgs2 Regulator of G-protein signaling 2 (RGS2). 
mMC019522 2.44 0.0356 Shroom1 Protein Shroom1. 
mMC014141 2.44 0.0378 Olfr123 olfactory receptor 123. 
mMR031232 2.44 0.001 Cux2 Homeobox protein cut-like 2. 
mMC000927 2.45 0.0395 Derl1 Degradation in endoplasmic reticulum protein 1. 
mMC004037 2.46 0.003 Angpt2 Angiopoietin-2 precursor. 
mMC010754 2.46 0.0229 Abca1 ATP-binding cassette sub-family A member 1. 
mMR027525 2.48 0.0067 Bmf Bcl-2-modifying factor. 
mMC025342 2.48 0.0176 Syp Synaptophysin (Major synaptic vesicle protein p38). 
mMC014959 2.49 0.0257 Id1 DNA-binding protein inhibitor, Inhibitor of DNA binding 1. 
mMR030256 2.5 0.0119 Evi1 Ecotropic virus integration site 1 protein. 
mMC023884 2.53 0.0392 Icos Inducible T-cell co-stimulator precursor. 
mMC011878 2.53 0.0329 Nrtn Neurturin precursor. 
mMC002262 2.53 0.0203 Tnnt1 Troponin T, slow skeletal muscle. 
mMC004603 2.55 0.0216 Pdlim3 PDZ and LIM domain protein 3. 
mMR029853 2.59 0.0046 Sox5 Transcription factor SOX-5. 
mMC015376 2.6 0.0122 Lgals3 Galectin-3 (Galactose-specific lectin 3). 
mMC025896 2.6 0.0032 Dbx1 Developing brain homeobox protein 1.  
mMC008166 2.61 0.0101 Olfr740 olfactory receptor 740 
mMC012597 2.62 0.0461 Nfkbia NF-kappa-B inhibitor alpha (I-kappa-B-alpha). 
mMC018691 2.62 0.0008 Dck Deoxycytidine kinase. 
mMC004630 2.64 0.0006 Yipf2 Protein YIPF2 (YIP1 family member 2). 
mMC015898 2.64 0.0002 Dkk1 Dickkopf-related protein 1 precursor. 
mMC001101 2.65 0.0266 Plac8 Placenta-specific gene 8 protein. 
mMC009367 2.65 0.0019 Atf3 Cyclic AMP-dependent transcription factor ATF-3. 
mMC007158 2.66 0.0021 Zfpm2 Zinc finger protein ZFPM2 (Friend of GATA protein 2). 
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mMC001049 2.7 0.0047 Thbs3 Thrombospondin-3 precursor. 
mMC018723 2.77 0.004 Epyc Epiphycan precursor (Dermatan sulfate proteoglycan 3). 
mMR030076 2.84 0.0063 Klf3 Krueppel-like factor 3. 
mMC012911 2.91 0.0019 Sox5 Transcription factor SOX-5. 
mMC008743 2.94 0.0169 Olfr1428 olfactory receptor 1428. 
mMC002022 2.96 0.0046 Vsx1 Visual system homeobox 1. 
mMC004722 2.97 0.0173 Olfr1423 olfactory receptor 1423. 
mMC005384 3.06 0.0204 Sepp1 Selenoprotein P precursor. 
mMC021603 3.06 0.0056 Fgf22 Fibroblast growth factor 22 precursor. 
mMC013726 3.16 0.0165 Nkx2-6 Homeobox protein Nkx-2.6. 
mMC004723 3.21 0.0015 Kap Kidney androgen-regulated protein precursor. 
mMC006543 3.24 0.0072 Olfr571 olfactory receptor 571. 
mMC006067 3.31 0.0028 Msx2 Homeobox protein MSX-2 (Hox-8.1). 
mMC012563 3.32 0.0038 Gadd45g Growth arrest and DNA-damage-inducible protein. 
mMC011946 3.51 0.0272 Eid1 EP300-interacting inhibitor of differentiation 1. 
mMC008354 3.59 0.0032 Sox8 Transcription factor SOX-8.  
mMC006928 3.63 0.0306 Actrt1 Actin-related protein T1. 
mMC007645 3.71 0.001 Bmf Bcl-2-modifying factor. 
mMC019148 3.75 0.0028 Col9a2 Collagen alpha-2(IX) chain precursor. 
mMC007751 3.84 0.0002 Hand1 Heart- and neural crest derivatives-expressed protein 1. 
mMC011983 3.9 0.0108 Odf1 Outer dense fiber protein 1. 
mMR028115 3.91 0.0027 Ntng1 Netrin-G1 precursor (Laminet-1).  
mMR029269 4.04 0.0007 Col9a1 Collagen alpha-1(IX) chain precursor. 
mMC002384 4.15 0.0022 Gadd45b Growth arrest and DNA-damage-inducible protein. 
mMC005244 4.24 0.0053 S100a8 S100 calcium-binding protein A8 (Calgranulin-A). 
mMC009186 4.26 0.0034 Tbx20 T-box transcription factor TBX20. 
mMC023939 4.43 0.0019 Gata6 Transcription factor GATA-6 (GATA-binding factor 6). 
mMC011282 4.46 0.0053 Fbxo2 F-box only protein 2.  
mMC012619 4.59 0.0052 Nog Noggin precursor. 
mMC008700 5.25 0.0003 Smad6 Mothers against decapentaplegic homolog 6. 
mMC008103 5.42 0.0002 Col9a3 procollagen, type IX, alpha 3. 
mMC020041 5.53 0.0022 Unc5b Netrin receptor UNC5B precursor. 
mMC005675 5.58 0.01 Angpt1 Angiopoietin-1 precursor (ANG-1).  
mMR029110 5.63 0.0005 Pdgfrl Platelet-derived growth factor receptor-like protein. 
mMC013000 6.25 0.0026 Gata2 Endothelial transcription factor GATA-2. 
mMC002592 7.32 0.0017 Igfbp7 Insulin-like growth factor-binding protein 7 precursor. 
mMC008257 7.74 0.0013 Rgs5 Regulator of G-protein signaling 5. 
mMC013455 7.89 6.84E-05 Isl1 Insulin gene enhancer protein ISL-1. 
mMC017480 9.68 0.0003 Bmp4 Bone morphogenetic protein 4 precursor. 
mMC021077 12.47 0.0031 Gata3 Trans-acting T-cell-specific transcription factor GATA-3. 
mMC007167 12.97 6.69E-05 Sct Secretin precursor. 
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